<DOC>
	<DOCNO>NCT00562354</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , immunogenicity 13-valent pneumococcal conjugate ( 13vPnC ) vaccine healthy Japanese adult age &gt; = 50 year .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Healthy Japanese Adults Aged &gt; = 50 Years</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Japanese descent male female adult potential bear child &gt; = 50 year age . Determined eligible study base medical history , physical examination , clinical judgment . Subjects preexist stable disease , define disease require significant change therapy hospitalization worsen disease 12 week receipt study vaccine , eligible . Sexually active men must agree commit use medically accept form contraception study least 3 month vaccination . History severe adverse reaction associate vaccine . Receipt vaccine within 30 day study vaccination , except influenza vaccine . Documented S pneumoniae infection within past 5 year study vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Vaccines , Pneumococcal Conjugate Vaccine</keyword>
</DOC>